Help us: Donate
Follow us on:

Rapamycin Improves the Viability of Egg Cells

it increases the number of human embryos that can develop into children.

In vitro fertilizationIn vitro fertilization

Researchers publishing in Aging have found that rapamycin, a molecule thoroughly researched for its effects on metabolism, improves the viability of egg cells (oocytes) grown in vitro.

Another approach towards a known problem

Decreased fertility in women occurs much more rapidly than other aspects of aging, and advanced maternal age has a substantial impact on pregnancy outcomes [1]. Researchers have previously approached this problem over multiple promising angles, including NAD+ and fibrosis, finding that oxidative stress and mitochondrial dysfunction are significant contributors.

These researchers have previously examined the effects of rapamycin on egg cells taken from mice, finding that it reduces reactive oxygen species (ROS) and protects against DNA damage [2]. This study builds on that work, using oocytes from aged mice and from women over the age of 35.

Effects on maturation, activity, and DNA protection

Taking oocytes from 40- to 48-week-old mice and cultivating them in vitro, the researchers found that 86% of the rapamycin-treated group matured, while only 75% of the control group matured. After a parthenogenic activation treatment, a form of simulated fertilization, more eggs in the rapamycin group showed signs of activation (54% to 41%) and cellular division (48% to 33%).

Similar positive effects were shown on chromosomal abnormalities. Roughly 39% of the control group had misaligned chromosomes, while only 20% of the rapamycin group did. Effects on chromosomal spindles and mitochondrial membranes seemed positive but were not statistically significant.

However, the effects on ROS and DNA damage were substantial and visible. Fluorescence from ROS was 14 in the rapamycin group and 49 in the control groupΒ  In the control group, the relative fluorescence of the DNA damage marker Ξ³-H2AX was roughly 2.5 times that of the rapamycin group.

Fertilized human oocytes benefit as well

Finally, the researchers examined a total of 131 oocytes taken from human women who had volunteered for in vitro fertilization. 64 of these oocytes were in the control group, and 67 were in the rapamycin group. While the rapamycin group showed greater maturation and germinal vesicle formation, due to the relatively low sample size, these positive results did not reach the level of statistical significance.

However, fertilized oocytes did benefit in a specific and important way. Comparing 39 fertilized eggs from the control group and 34 from the rapamycin group, they found that the rates of normal fertilization were no different, but the number of high-quality embryos was substantially different: the rapamycin group had 12, while the control group had only 5. These are the embryos that are most likely to survive through development and childbirth.


The researchers note that these results are positive, but not as positive as they might have liked. Rapamycin was shown to ameliorate many problems with chromosomes and genetic damage. However, it appears to be unable to help cells repair double-stranded DNA breaks, which are more common in oocytes derived from women over 35, and the researchers believe that this may have affected the results.

A combination treatment of NAD+ boosters, rapamycin or rapalogs, and additional compounds that enhance DNA repair may be the near-future path forward for improving the success rates of in vitro fertilization. More research in this area is clearly needed.

We would like to ask you a small favor. We are a non-profit foundation, and unlike some other organizations, we have no shareholders and no products to sell you. We are committed to responsible journalism, free from commercial or political influence, that allows you to make informed decisions about your future health.

All our news and educational content is free for everyone to read, but it does mean that we rely on the help of people like you. Every contribution, no matter if it’s big or small, supports independent journalism and sustains our future. You can support us by making a donation or in other ways at no cost to you.

Hypoxia Extends Median Lifespan in Fast-Aging Mice by 50%

Scientists have found that continuous oxygen restriction drastically extends the lifespan of progeroid mice, but the effect's mechanism remains a...

Discovering Why Adrenal Cancer Is More Dangerous for Women

A paper published today in Nature Aging has explained a relationship between cellular senescence, cancer of the adrenal glands, and...

Using AI to Discover New Rapamycin-Like Molecules

In a recent paper published in International Journal of Medical Sciences, researchers have described how they used artificial intelligence and...

How Your Funding Has Helped Mitochondrial Research

Financed by's crowdfunding efforts, SENS Research Foundation has engaged in fruitful research into ways of dealing with mitochondrial dysfunction,...


[1] Attali, E., & Yogev, Y. (2021). The impact of advanced maternal age on pregnancy outcome. Best Practice & Research Clinical Obstetrics & Gynaecology, 70, 2-9.

[2] Yang, Q., Xi, Q., Wang, M., Long, R., Hu, J., Li, Z., … & Jin, L. (2022). Rapamycin improves the quality and developmental competence of mice oocytes by promoting DNA damage repair during in vitro maturation. Reproductive Biology and Endocrinology, 20(1), 1-11.

About the author
Josh Conway

Josh Conway

Josh is a professional editor and is responsible for editing our articles before they become available to the public as well as moderating our Discord server. He is also a programmer, long-time supporter of anti-aging medicine, and avid player of the strange game called β€œreal life.” Living in the center of the northern prairie, Josh enjoys long bike rides before the blizzards hit.
No Comments
Write a comment:


Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.